Company Name RUSSET THERAPEUTICS PRIVATE LIMITED

CIN CIN : U51909AP2021PTC119335

Address RAJAMAHENDRAVARAM
Period 01-04-2023 to 31-03-2024
Period Ended 31st March, 2024
Current Year end 01-04-2023 to 31-03-2024 Rs. In Lakhs 100000
Previous year end 01-04-2022 to 31-03-2023

Company Director 1 DIN - 09306625

Company Director 2 DIN: 09306626

CA Details
For SATISH & SURESH

(Satish Kumar Nathipom)

Partner
M.No : 252696
Place: Rajamahendravaram
Date: 28-11-2022
UDIN : 22252696BGBKNQ1989
 RUSSET THERAPEUTICS PRIVATE LIMITED
CIN : U51909AP2021PTC119335
RAJAMAHENDRAVARAM

Rs. In Lakhs

STATEMENT OF PROFIT & LOSS FOR FY 2023-24

&

BALANCE SHEET

AS ON 31--03--2024

( ACCOUNTING YEAR 2023-24 )

 RUSSET THERAPEUTICS PRIVATE LIMITED
CIN : U51909AP2021PTC119335
RAJAMAHENDRAVARAM

PART I - Balance Sheet As On 31st March, 2024

Particulars Note Figures as at the end Figures as at the end of

No. of current reporting previous reporting
period Period
01-04-2023 to 01-04-2022 to 31-03-
31-03-2024 2023
Rs. In Lakhs Rs. In Lakhs
A EQUITY AND LIABILITIES

1 Shareholders’ funds
(a) Share capital 1 40.00 40.00
(b) Reserves and surplus 2 (20.24) (19.46)
(b) Money Received against share warrents - -
2 Share application money pending allotments - -
3 Non-current liabilities
(a) Long-term borrowings 3 35.75 22.00
(b) Deferred tax liabilities (net) - -
(c) Other Long Term Liabilities -
(d) Long term provision -
4 Current liabilities
(a) Short Term Borrowings 4 - -
(b) Trade payables 5
(A) total outstanding dues of micro enterprises and small
enterprises
(B) total outstanding dues of Creditors other than micro 10.24 0.28
enterprises and small
(c) Other current enterprises
liabilities 6 5.00 6.60
(d) Short-term provisions 7 0.54 0.45

TOTAL 71.29 49.87

B ASSETS

1 Non-current assets
(a) Property, Plant and 8
Equipment and
(i) Property, Plant and Equipment 1.42 2.30
Intangible(ii)
assets
Intangible assets - -
(iii) Capital Work in progress - -
(iv) Intangible Assets under Development - -
(b) Non-current investments 9 - -
(c) Deferred Tax Assets
(d) Long term loans and Advances
(e) Other Non Current Assets

2 Current assets
(a) Current Investments 10
(b) Inventories 11 9.25 6.27
(c) Trade receivables 12 56.93 38.99
(d) Cash and cash equivalents 13 3.46 2.24
(e) Short-term loans and advances 14 0.22 0.07
(f) Other Current Assets 15 - -
TOTAL 71.29 49.87
See accompanying notes forming part of the financial statements - -
In terms of our report attached.
For SATISH & SURESH FOR RUSSET THERAPEUTICS PRIVATE LIMITED
Chartered Accountants

(Satish Kumar Nathipom)

Partner (DIRECTOR) (DIRECTOR)
M.No : 252696 DIN - 09306625 DIN: 09306626
Place: Rajamahendravaram
Date: 28-11-2022
UDIN : 22252696BGBKNQ1989
 RUSSET THERAPEUTICS PRIVATE LIMITED
CIN : U51909AP2021PTC119335
RAJAMAHENDRAVARAM

PART II - STATEMENT OF PROFIT AND LOSS ACCOUNT FOR THE YEAR ENDED 31st MARCH 2024

Particulars Note Figures for the current Figures for the previous
No. reporting period reporting period

01-04-2023 to 31- 01-04-2022 to 31-03-

03-2024 2023
Rs. In Lakhs Rs. In Lakhs

I Revenue from operations 16 125.84 77.86

II Other Income 17 - -

III Total Income (I+II) 125.84 77.86

IV Expenses
(a) Cost of materials consumed 18 27.31 20.28
(b) Purchase of Stock in Trade
(c) Changes in inventories of finished goods, work-in-progress 19 - -
and stock-in-trade
(d) Employee benefits expenses 20 66.49 40.98
(e) Finance costs 21 3.22 1.26
(f) Depreciation and amortisation expenses 0.88 0.97
(g) Other expenses 22 28.78 23.63

Total Expenses 126.68 87.11

V Profit before exceptional and extraordinary item and tax (0.84) (9.25)

VI Exceptional Items - -

VII Profit before extraordinary item and tax (0.84) (9.25)

VIII Extraordinary Items - -

IX Profit before Tax (0.84) (9.25)

X Tax Expense:
(a) Current tax expense - -
(b) Deferred tax (0.07) (0.01)

XI Profit / (Loss) for the period from continuing operations (0.77) (9.24)
XII Profit / (Loss) from discontinuing operations - -
XIII Tax expense of discontinuing operations - -
XIV Profit/ (Loss) from discontinuing operations - -

XV Profit/ (Loss) for the Period (0.77) (9.24)

XVI Earning per equity share:in Rupees

(1) Basic (0.19) (2.31)
(2) Diluted (0.19) (2.31)
See accompanying notes forming part of the financial statements
In terms of our report attached.
For SATISH & SURESH FOR RUSSET THERAPEUTICS PRIVATE LIMITED
Chartered Accountants

(Satish Kumar Nathipom)

Partner (DIRECTOR) (DIRECTOR)
M.No : 252696 DIN - 09306625 DIN: 09306626
Place: Rajamahendravaram
Date: 28-11-2022
UDIN : 22252696BGBKNQ1989
 RUSSET THERAPEUTICS PRIVATE LIMITED
CIN : U51909AP2021PTC119335
RAJAMAHENDRAVARAM

PART III - CASH FLOW STATEMENT FOR THE YEAR ENDED 31st MARCH, 2024

Particulars Figures for the Figures for the

current reporting previous
period reporting period
01-04-2023 to 01-04-2022 to
31-03-2024 31-03-2023
Rs. In Lakhs Rs. In Lakhs
A. CASH FLOW FROM OPERATING ACTIVITIES

Net profit before tax and extraordinary items - -

Adjustments for:
Depreciation and amortisation expense - -
(Profit) / Loss on sale of fixed assets
(Profit) / Loss on redemption of investments
Interest and other income on investments
Interest expenses
Appropriation of profits - -

Operating profit / (loss) before working capital changes - -

Changes in working capital:
Increase / (Decrease) in trade payable
Increase / (Decrease) in short term borrowing
Increase / (Decrease) in provisions
Increase / (Decrease) in deferred tax liabilities
Increase / (Decrease) in other current liabilities
(Increase) / Decrease in short term loan and advances
(Increase) / Decrease in trade receivables
(Increase) / Decrease in inventories
- -
CASH FLOW FROM / (USED IN) OPERATING ACTIVITIES - -
Less: Taxes paid
NET CASH FLOW FROM / (USED IN) OPERATING ACTIVITIES - -

B. CASH FLOW FROM INVESTING ACTIVITIES

Purchase of tangible / intangible assets
Sale of tangible / intangible assets
(Increase) / Decrease in long term loan and advances
(Increase) / Decrease in non current investments
(Profit)/Loss on redemption of investments
Investment in fixed deposits - -
Dividend/ bank interest received - -
NET CASH FLOW FROM / (USED IN) INVESTING ACTIVITIES - -

C. CASH FLOW FROM FINANCING ACTIVITIES

Interest expenses - -
Funds borrowed
Dividend paid - -
NET CASH FLOW FROM / (USED IN) FINANCING ACTIVITIES - -
NET INCREASE / (DECREASE) IN CASH & CASH EQUIVALENTS (A+B+C) - -
Cash and Cash equivalents at beginning period - -
Cash and Cash equivalents at end of period - -
D. Cash and Cash equivalents comprise of
Cash on hand
Balances with banks
In current accounts
Total - -
This Cash Flow Statement has been prepared as per "Indirect Method" as prescribed by Accounting Standard -3 (revised) "Cash Flow
Statements"
See accompanying notes forming part of the financial statements
In terms of our report attached.
For FOR RUSSET THERAPEUTICS PRIVATE LIMITED
Chartered Accountants

(Satish Kumar Nathipom)

Partner (DIRECTOR) (DIRECTOR)
M.No : 252696 DIN - 09306625 DIN: 09306626
Place: Rajamahendravaram
Date: 28-11-2022
UDIN : 22252696BGBKNQ1989
 RUSSET THERAPEUTICS PRIVATE LIMITED
NOTES ANNEXED TO AND FORMING PART OF THE BALANCE SHEET
Note -1. SHARE CAPITAL Rupees
Particulars Figures as at the end of current reporting period Figures as at the end of previous reporting
Number of shares Rs. In Lakhs Number of shares Period Rs. In Lakhs
(a) Authorised 490,000 49 490,000 49
300000 Equity shares of Rs.10/- each
with voting rights
(b) Issued, Subscribed and Paid up 400,000 40 400,000 40
200000 Equity shares of Rs.10 each
with voting rights
Total 400,000.00 40.00 400,000.00 40.00
List of Shareholders holding more than 5% share capital
Name of Shareholders No. of Shares % of Holding Face Value per Share Total Value in Lakhs
S BHARATHI 60000 15.00 10 6
S RAVI GOPAL 50000 12.50 10 5
T V NAGESWARA RAO 80000 20.00 10 8
T CHAKRA PANI 30000 7.50 10 3
DASARI SREENU 40000 10.00 10 4
Akula Naga Lakshmi 50000 12.50 10 5
B Yaswanth Raj 50000 12.50 10 5
Jakka Durga Prasad 40000 10.00 10 4
TOTAL 400,000 100 40.00

NOTE 1A. SHARES HELD BY PROMOTORS

Current Reporting Period
Sr No. Promotor's Name No of shares % of total shares % Change during the year
1 S BHARATHI 60000 15.00 0.00
2 S RAVI GOPAL 50000 12.50 0.00
3 T V NAGESWARA RAO 80000 20.00 0.00
4 T CHAKRA PANI 30000 7.50 0.00
5 DASARI SREENU 40000 10.00 0.00
6 Akula Naga Lakshmi 50000 12.50 0.00
7 B Yaswanth Raj 50000 12.50 0.00
8 Jakka Durga Prasad 40000 10.00 0.00
100.00 0.00
Previous reporting Period
Sr No. Promotor's Name No of shares % of total shares % Change during the year
1 S BHARATHI 60000 15.00 0.00
2 S RAVI GOPAL 50000 12.50 0.00
3 T V NAGESWARA RAO 80000 20.00 0.00
4 T CHAKRA PANI 30000 7.50 0.00
5 DASARI SREENU 40000 10.00 0.00
6 Akula Naga Lakshmi 50000 12.50 0.00
7 B Yaswanth Raj 50000 12.50 0.00
8 Jakka Durga Prasad 40000 10.00 0.00
100.00 0.00

NOTE- 1B. STATEMENTS OF CHANGES IN EQUITY in Lakhs

Current Reporting Period
Balance at the beginning of the Changes in Equity Share Related Balance at the Changes in Equity Balance at the end of the
current reporting period Capital due to prior beiginning of the Share Capital during current reporting period
period error current reporting the current year
periuod

6 6
5 5
8 8
3 3
4 4
5 5
5 5
4 4
40 - 40
Previous reporting Period
Balance at the beginning of the Changes in Equity Share Related Balance at the Changes in Equity Balance at the end of the
previous reporting period 3 Capital due to prior beginning of the Share Capital during3 previous reporting 6
5 period error previous reporting the previous year 3 period 8
periuod
5 5 10
3 5 8
4 4 8
20 20 40
In terms of our report attached.
For SATISH & SURESH
Chartered Accountants
FOR RUSSET THERAPEUTICS PRIVATE LIMITED

(Satish Kumar Nathipom)

Partner
M.No : 252696
Place: Rajamahendravaram (DIRECTOR) (DIRECTOR)
Date: 28-11-2022 DIN - 09306625 DIN: 09306626
UDIN : 22252696BGBKNQ1989
 RUSSET THERAPEUTICS PRIVATE LIMITED
NOTES ANNEXED TO AND FORMING PART OF THE BALANCE SHEET
Note 2 RESERVES AND SURPLUS
Particulars Figures as at the end of Figures as at the end of previous reporting
current
Rs.reporting
In Lakhsperiod Rs.Period
In Lakhs
(A) Securities premium account
Opening balance - -
Closing balance - -

(B) Surplus / (Deficit) in Statement of

Profit
Openingand Loss
balance (19.46) (10.22)
Add: Profit / (Loss) for the year (0.78) (9.24)
Less:- Loss Due to Change in Rate of - -
Depriciation as per Company Act 2013
Closing balance (20.24) (19.46)

Total (20.24) (19.46)

Note 3 LONG TERM BORROWINGS

Particulars Figures as at the end of Figures as at the end of previous reporting

current reporting period Period
Rs. In Lakhs Rs. In Lakhs
UNSECURED LOANS
-
Loan from Director & Relatives - -
Naga Lakshmi Akula 15.00 5.00
Ravi Gopal S 10.75 7.00
T V Tatarao 10.00 -
Akula satyanaryana 10.00

TOTAL 35.75 22.00

Note 4 SHORT TERM BORROWINGS

Particulars Figures as at the end of Figures as at the end of previous reporting
currentRs.
reporting
In Lakhs period Period Rs. In Lakhs
SECURED LOANS
OD A/C - -
CASH CREDIT - -
(Secured against hypothecation of Stocks - -
and Personal guarantee of Directors and - -
equitable mortgaged of Factory Land and - -
Building) - -

TOTAL - -
Note 6 OTHER CURRENT LIABILITIES
Particulars Figures as at the end of Figures as at the end of previous reporting
currentRs.
reporting
In Lakhs period Period Rs. In Lakhs
Creditors For Advance 5.00 2.60
Expenses Payable - 4.00
Others - -
Total 5.00 6.60

Note 7 SHORT TERM PROVISIONS

Particulars Figures as at the end of Figures as at the end of previous reporting
currentRs.
reporting
In Lakhs period Period Rs. In Lakhs
(a) Provision for employee benefits
ESI Employees Contribution Payable - -
ESI Employers Contribution Payable - -
Professional Tax - -
Wages Payable - -
Salary Payable 0.54 0.10

(b) Provision - for TAX

Provision for Income Tax(Prior Years) - 0.00
Provision for Income Tax(Current Years) - 0.12
TDS Payable - -
(c) Provision - Others
Power Payable - -
Telephone Exp. Payable - -
GST Payable - 0.22
Other Payables - -
Audit Fees Payable - -

Total 0.54 0.45

In terms of our report attached.
For Satish & Suresh FOR RUSSET THERAPEUTICS PRIVATE
LIMITED
Chartered Accountants

(Satish Kumar Nathipom)

Partner (DIRECTOR) (DIRECTOR)
M.No : 252696 DIN - 09306625 DIN: 09306626
Place: Rajamahendravaram
Date: 28-11-2022
UDIN : 22252696BGBKNQ1989
 RUSSET THERAPEUTICS PRIVATE LIMITED
Note 9 NON CURRENT INVESTMENTS

Particulars Figures as at the Figures as at the end of previous

end of current
Rs. In Lakhs reporting Period
Rs. In Lakhs
Fixed Deposit reporting period- -

Total - -

Note 11 INVENTORIES
(At lower of cost and net realisable value)

Particulars Figures as at the Figures as at the end of previous

end of current
Rs. In Lakhs reporting Period
Rs. In Lakhs
Finished Goods reporting period9 6
Raw Material (including Packing Material) - -
WIP - -
Stock with Consignee - -
Total 9 6.27

Note 13 CASH AND CASH EQUIVALENTS

Particulars Figures as at the Figures as at the end of previous

end of current
Rs. In Lakhs reporting Period
Rs. In Lakhs
A) Cash In Hand reporting period1 0.23
B) Bank Balance 2 2.00

Total 3 2.24
Note 14 SHORT TERM LOANS AND ADVANCES

Particulars Figures as at the Figures as at the end of previous

end of current
Rs. In Lakhs reporting Period
Rs. In Lakhs
reporting period
Advances for Purchases - -
Advances to Suppliers - -
Security Deposit with RICL - -
Security Deposit with BSNL - -
Additional Tax Recoverable C.G. - -
GST INPUT 0 -
Others - DTA 0.12 0.07
TDS Receivable P.Y - -
TDS Receivable A.Y 2022-23 - -
Total 0 0.07
Note 15 OTHER CURRENT ASSETS

Particulars Figures as at the Figures as at the end of previous

end of current
Rs. In Lakhs reporting Period
Rs. In Lakhs
A) Preliminary exps. w/off reporting period- -
B) fixed assets scrap - -
C) other - -
Total - -
In terms of our report attached.
For Satish & Suresh
Chartered Accountants FOR RUSSET THERAPEUTICS PRIVATE
LIMITED

(Satish Kumar Nathipom)

Partner
M.No : 252696 (DIRECTOR) (DIRECTOR)
Place: Rajamahendravaram DIN - 09306625 DIN: 09306626
Date: 28-11-2022
UDIN : 22252696BGBKNQ1989
Note 5 TRADE PAYABLES

Figures For the Current Reporting Period

Outstanding for following periods from due date of
payment
Particulars More
Less than 1 Year 1-2 Years 2-3 Years than 3 Total
Years
MSME - - - - -
Others 10.24 - - - 10.24
Dispute dues-MSME - - - - -
Dispute dues - - - - -
Others - - - - -
Total 10.24

Figures For Previous Reporting Period

Outstanding for following periods from due date of
payment
Particulars More
Less than 1 Year 1-2 Years 2-3 Years than 3 Total
Years
MSME - - - - -
Others 0.28 - - - 0.28
Dispute dues-MSME - - - - -
Dispute dues - - - - -
Others - - - - -
Total 0.28

Note 12 TRADE RECEIVABLES

Figures For the Current Reporting Period
Outstanding for following periods from due date of payment

Particulars 6 Months - 2-3

Less than 6 Months 1-2 Years More than 3 Years Total
1Year Years
Undisputed Trade Receivables-
Considered
Undisputed Goods
Trade Receivables- 57 - - - - 57
Considered Doubtful
Disputed Trade Receivables- - - - - - -
Considered Goods
Disputed Trade Receivables- - - - - - -
Considered Doubtful - - - - - -
Others -

Figures For Previous Reporting Period

Outstanding for following periods from due date of payment
Particulars 6 Months - 2-3
Less than 6 Months 1-2 Years More than 3 Years Total
1Year Years
Undisputed Trade Receivables-
Considered
Undisputed Goods
Trade Receivables- 38.99 - - - - 38.99
Considered Doubtful
Disputed Trade Receivables- - - - - - -
Considered
Disputed Goods
Trade Receivables- - - - - - -
Considered Doubtful - - - - - -
Others -
 RUSSET THERAPEUTICS PRIVATE LIMITED
DEPRECIATION STATEMENT FOR THE YEAR ENDED 31.03.2024

USEFUL
LIFE AS
PER DATE OF REMAINI WDV AS ON RESIDUAL WRITTE RATE OF DEPRECIATIO WDV AS ON
SCH. II ACQUISITIO NG LIFE 01.04.23 (RS.) or VALUE N OFF DEPRECIAT N AMOUNT 31.03.24
S.NO COMPONENT NAME CATEGORY (YEARS) N (YEARS) Cost of Asset Cost of Purchase (RS.) (RS.) ION (%) (RS.) (RS.)
1 Air Conditioner Electrical Installation & Equipments 10 01.12.2021 8 24,609.38 19,933.60 1,230.47 - 11.728395 2,337.89 17,595.71
2 Computer & Accessories Computers - End User Devices like Desktop, Laptops 3 06.11.2021 1 89,089.83 32,666.27 4,454.49 - 86.363636 28,211.78 4,454.49
3 Electrical Items Electrical Installation & Equipments 10 15.09.2021 8 12,900.00 10,449.00 645.00 - 11.728395 1,225.50 9,223.50
4 Furniture & Fixtures Furniture - General 10 02.10.2021 8 7,627.00 6,177.87 381.35 - 11.728395 724.56 5,453.31
5 Softwares & Licenses Computers - End User Devices like Desktop, Laptops 3 12.11.2021 1 84,746.00 31,073.53 4,237.30 - 86.363635 26,836.23 4,237.30
6 Storage Refrigerator Office Equipments 5 21.10.2021 3 13,700.00 8,494.00 685.00 - 30.645161 2,603.00 5,891.00
7 Projector Office Equipments 5 1/1/2023 5 31,078.00 25,173.18 1,553.90 - 18.765432 4,723.86 20,449.32
8 I Phone Office Equipments 5 6/22/2022 5 86,288.14 69,893.39 4,314.41 - 18.765432 13,115.80 56,777.59
9 Softwares & Licenses Computers - End User Devices like Desktop, Laptops 3 9/30/2022 3 25,000.00 17,083.33 1,250.00 - 30.894308 5,277.78 11,805.55
10 Softwares & Licenses Computers - End User Devices like Desktop, Laptops 3 1/30/2023 3 13,950.00 9,532.50 697.50 - 30.894309 2,945.00 6,587.50
230,476.67 88,001.40 142,475.27
 Note - 8
RUSSET THERAPEUTICS PRIVATE LIMITED
STATEMENT OF FIXED ASSETS, AS ON 31 ST MARCH 2024 Rs. In Lakhs
PARTICULARS CATEGORY G R O S S ------- B L O C K DEPRECIATION N E T -- B L O C K

AS ON ADDITIONS DELETIONS AS ON UP TO FOR THE AS ON AS ON AS ON

4/1/2023 31.3.2024 01.04.2023 YEAR 31.03.2024 31.03.2024 31.03.2023

Air Conditioner Electrical Installation & Equipments 0.25 - - 0.25 0.05 0.02 0.07 0.18 0.20
Computer & Accessories Computers - End User Devices like Desktop, Laptops 0.89 - - 0.89 0.56 0.28 0.85 0.04 0.33
Electrical Items Electrical Installation & Equipments 0.13 - - 0.13 0.02 0.01 0.04 0.09 0.10
Furniture & Fixtures Furniture - General 0.08 - - 0.08 0.01 0.01 0.02 0.05 0.06
Softwares & Licenses Computers - End User Devices like Desktop, Laptops 0.85 - - 0.85 0.54 0.27 0.81 0.04 0.31
Storage Refrigerator Office Equipments 0.14 - - 0.14 0.05 0.03 0.08 0.06 0.08
Projector Office Equipments 0.31 - - 0.31 0.06 0.05 0.11 0.20 0.25
I Phone Office Equipments 0.86 - - 0.86 0.16 0.13 0.30 0.57 0.70
Softwares & Licenses Computers - End User Devices like Desktop, Laptops 0.25 - - 0.25 0.08 0.05 0.13 0.12 0.17
Softwares & Licenses Computers - End User Devices like Desktop, Laptops 0.14 - - 0.14 0.04 0.03 0.07 0.07 0.10
TOTAL 3.89 - - 3.89 1.59 0.88 2.47 1.42 2.30
PREVIOUS YEAR
In terms of our report attached.
For SATISH & SURESH For RUSSET THERAPEUTICS PRIVATE LIMITED
Chartered Accountants

(Satish Kumar Nathipom)

Partner (DIRECTOR) (DIRECTOR)
M.No : 252696 DIN - 09306625 DIN: 09306626
Place: Rajamahendravaram
Date: 28-11-2022
UDIN : 22252696BGBKNQ1989
 ANNEXURE - A
RUSSET THERAPEUTICS PRIVATE LIMITED
Particulars of Depreciation allowable as per the Income Tax Act, 1961 in respect of each asset or block of asset as the case may be. 31st MARCH, 2024
Rs. In Lakhs 100000
SL. RATE Addition during the year Deductions
NO. PARTICULARS OF WDV as on More than Less than during the TOTAL Depreciation WDV as on
DEP. 01.04.2023 180 days 180 days year AMOUNT allowable 31.03.2023

1 AIR CONDITIONER 15% - - - - - - -

2 COMPUTER EQUIPMENT 40% 1.10 - - - 1.10 0.44 0.66
3 ELECTRIC & FURNITURES 15% - - - - - - -
4 PLANT & MACHINERY 15% - - - -
5 Equipement 15% 1.47 - - - 1.47 0.22 1.25
6 LAND 0% - - - - - -
7 BUILDING 10% - - - -
8 Plinth No. 5 & 6 0% - - - - -
Current Year Total :- 2.57 - - - 2.57 0.66 1.91
In terms of our report attached.
For SATISH & SURESH
Chartered Accountants For RUSSET THERAPEUTICS PRIVATE LIMITED

(Satish Kumar Nathipom)

Partner
M.No : 252696 (DIRECTOR) (DIRECTOR)
Place: Rajamahendravaram DIN - 09306625 DIN: 09306626
Date: 28-11-2022
UDIN : 22252696BGBKNQ1989

Working Note:

Calculation of Deferred Tax

Taxable Income
accounting Incom -
Add: Dep cos act 0.88
0.88
Less: Dep IT Act 0.66
Accounting Income or PBT - 0.22
Tax on accounting Income - Prov fot I.T 0.06

Since PBT is more than Taxable Income there is Deferred Tax Liability.

Hence Deferred Tax Liability -

Current Tax 0.06
Note 16 REVENUE FROM OPERATIONS (IN LAKHS)
Figures for the current Figures for the previous reporting
reporting period period
Particulars

Rs. In Lakhs Rs. In Lakhs

Sale of Services 125.84 77.86

Total - Sales 125.84 77.86

Note 17 OTHER INCOME

Figures for the current Figures for the previous reporting
Particulars reporting period period

Rs. In Lakhs Rs. In Lakhs

Other Income - -
Total - -
Note 18 COST OF MATERIALS CONSUMED

Figures for the current Figures for the previous reporting

reporting period period
Particulars
Rs. In Lakhs Rs. In Lakhs
Opening stock 6.27 5.64

Add: Purchases
Import
Domestic 30.29 20.91
20.91

Less: Closing stock 9.25 6.27

Cost of material consumed 27.31 20.28

Note 19 CHANGE IN INVETORIES
Particulars Figures for the current Figures for the previous reporting
reporting period period

Rs. In Lakhs Rs. In Lakhs

Inventories at the end of the year:
Finished goods -
Work-in-progress -
-
Inventories at the beginning of the year:
Finished goods -
Work-in-progress -
-
Net (increase) / decrease -

Note 20 EMPLOYEE BENEFIT EXPENSES

Particulars Figures for the current Figures for the previous reporting
reporting period period

Rs. In Lakhs Rs. In Lakhs

Salaries and wages 50.59 36.22
ESI & PF Employees Contribution 5.15 4.43
Staff Welfare 10.75 0.20
Professional Tax For Employees - 0.12
Total 66.49 40.98

Note 21 FINANCE COST

Figures for the current Figures for the previous reporting
reporting period period
Particulars

Rs. In Lakhs Rs. In Lakhs

Bank Charges - -
Interest on Unsecured loan 3.22 1.26
Interest On Late Payment - -
-
Total 3.22 1.26
In terms of our report attached.
For Satish & Suresh FOR RUSSET THERAPEUTICS PRIVATE
LIMITED
Chartered Accountants

(Satish Kumar Nathipom)

Partner (DIRECTOR) (DIRECTOR)
M.No : 252696 DIN - 09306625 DIN: 09306626
Place: Rajamahendravaram
Date: 28-11-2022
UDIN : 22252696BGBKNQ1989
Note 22 OTHER EXPENSES
Figures for the current Figures for the previous reporting
reporting period period
Particulars
Rs. In Lakhs Rs. In Lakhs
(A) DIRECT EXPENSES
Consumables 0.15 0.10
Generator Exp. - -
Power & Fuel - 0.02
Job Charges - -
Freight Inward - -
Unloading & Handling charges 0.22 0.29
Total (A) 0.37 0.41
(B) INDIRECT EXPENSES
Professional Fees 0.54 0.30
Directors Remuneration 15.00 14.68
Audit Fees 0.40 0.20
ROC Annual Filing Charges 1.15 0.11
Rent Office 0.12 0.36
Insurance 0.40 0.31
Business promotional Expenses 0.94 0.43
Comuter Maintenance 0.71 -
Other Expenses 0.70 1.26
Courier Charges 3.39 1.43
Telephone 0.06 0.06
Travel 0.56 0.79
Stationary 0.82 1.14
Gift/Promotions 0.66
Priliminary Expenses W/off -
Commission Expenses 2.95 2.15
Total (B) 28.41 23.23
Total (A+B) 28.78 23.63
In terms of our report attached.
For Satish & Suresh FOR RUSSET THERAPEUTICS
PRIVATE LIMITED
Chartered Accountants

(Satish Kumar Nathipom)

Partner (DIRECTOR) (DIRECTOR)
M.No : 252696 DIN - 09306625 DIN: 09306626
Place: Rajamahendravaram
Date: 28-11-2022
UDIN : 22252696BGBKNQ1989
 RUSSET THERAPEUTICS PRIVATE LIMITED Relevant Para of the CARO 2020 - 3(xix)

Ratio Analysis Numerator 31-Mar-22 31-Mar-21 Denominator 31-Mar-22 31-Mar-21 31-Mar-22 31-Mar-21

1 Current Ratio Current Assets Current Liabilities

Inventories Creditors for goods and
Sundry Debtors services
Short term loans
Cash and Bank balances Bank Overdraft
Receivables/Accruals Cash Credit
Loans and Advances Outstanding Expenses
Disposable Investments Provision for taxation
Any other current assets Proposed dividend
Unclaimed Dividend
Any other current liabilities
- - - - #DIV/0! #DIV/0!

2 Debt Equity Ratio Total Liabilities Shareholder's Equity

Total Outside Liabilities - Total Shareholders Equity - #DIV/0! #DIV/0!

3 Debt Service Coverage Ratio Net Operating Income Debt Service

(For Ind AS Companies Profit
Net Profit after tax + non-cash - Current Debt Obligation #DIV/0! #DIV/0!
before OCI)
operating expenses like (Interest & Lease payment+
depreciation and other Principal Repayment.
4 Return on Equity Ratio amortizations
Profit for the+period
Interest+other Avg. Shareholders Equity
Net Profit after taxes - preference - (Beginning shareholders' - #DIV/0! #DIV/0!
dividend (if any) equity + Ending
shareholders' equity) ÷ 2

5 Inventory Turnover Ratio Cost of Goods sold Average Inventory

(Opening Stock + Purchases) – - (Opening Stock + Closing - #DIV/0! #DIV/0!
Closing Stock Stock)/2

Trade Receivables Turnover

6 Net Credit Sales Average Trade
Ratio
Credit Sales - Receivables
(Beginning Trade - #DIV/0! #DIV/0!
Receivables + Ending Trade
Receivables) / 2
7 Trade Payables Turnover Ratio Total Purchases Average Trade Payables
Annual Net Credit Purchases - (Beginning Trade Payables + - #DIV/0! #DIV/0!
Ending Trade Payables) / 2

8 Net Capital Turnover Ratio Net Sales Average Working Capital

Total Sales - Sales Return - Current Assets - Current - #DIV/0! #DIV/0!
Liabilities

9 Net Profit Ratio Net Profit Net Sales

Profit After Tax - Sales - #DIV/0! #DIV/0!

Capital Employed = Tangible Net

10 Return on Capital employed EBIT Capital
Worth Employed
+ Total *
Debt + Deferred
Profit before Interest and Taxes - Tax Liability - #DIV/0! #DIV/0!

11 Return on Investment Return/Profit/Earnings Investment ** - #DIV/0! #DIV/0!

* Capital Employed could be treated three ways

Total Assets - Current Labilities

Fixed Assets + Working Capital
Equity + Long Term Debt

*** ROI as per GN

ROI = {MV(T1) – MV(T0) – Sum [C(t)]}
{MV(T0) + Sum [W(t) * C(t)]}

where, T1 = End of time period

T0 = Beginning of time period
t = Specific date falling between T1 and T0
MV(T1) = Market Value at T1
MV(T0) = Market Value at T0
C(t) = Cash inflow, cash outflow on specific date
W(t) = Weight of the net cash flow (i.e. either net inflow or net outflow) on day ‘t’, calculated as [T1 – t] / T1
Companies may provide ROI separately for each asset class (e.g., equity, fixed income, money market, etc.).
 I Title deeds of immovable Property not held in name of the Company
Wheather title deed holder is a
promotor, director or relative Property held Reason for not
Relevant line iteams in the Balance Title deeds of immovable Property not
Descriptions of Iteam of property Gross carrying Value of Promotor' director or since which being held in the
sheets held in name of the Company
employee of promotors/ date name of company
director

II Where the Company has revalued its Property, Plant and Equipment, the company shall disclose as to whether the revaluation is based on the valuation by a registered valuer as defined under rule 2 of the Companies (Registered Valuers and Valuation) Rules, 2017

III where Loans or Advances in the nature of loans are granted to promoters, directors, KMPs and the related parties (as defined under
Companies Act, 2013,) either severally or jointly with any other person, that are:
(a) repayable on demand or
(b) without specifying any terms or period of repayment
Percentage to the
Amount of loan and Advance in the total Loans and
Type of Borrower
nature of Loan outstanding Advances in the
nature of loans
Promotors
Directors
KMPs
Related Parties

IV Capital Work In Progress (CWIP)

(a) For Capital-work-in progress, following ageing schedule shall be given
Amount in CWIP for a period of
CWIP Total
Less than 1 year 1-2 years 2-3 Years More than 3 years
Projects in progress
Projects temporarily suspended

(b) For capital-work-in progress, whose completion is overdue or has exceeded its cost compared to its original plan, following
To be Completed in
CWIP Total
Less than 1 year 1-2 years 2-3 Years More than 3 years
Project 1
Project 2

V Intangible assets under development:

(a) For Intangible assets under development
Instangible Assets under Amount in CWIP for a period of
Total
Development Less than 1 year 1-2 years 2-3 Years More than 3 years
Project 1
Project 2

(b) Intangible assets under development completion schedule

Instangible Assets under To be Completed in
Total
Development Less than 1 year 1-2 years 2-3 Years More than 3 years
Project 1
Project 2

VI Details of Benami Property held

VII Where the Company has borrowings from banks or financial institutions on the basis of current assets
(a) whether quarterly returns or statements of current assets filed by the Company with banks or financial institutions are in agreement with the books of accounts.
(b) if not, summary of reconciliation and reasons of material discrepancies, if any to be adequately disclosed

VIII a. Date of declaration as wilful defaulter,

Wilful Defaulter
b. Details of defaults (amount and nature of defaults),

IX Relationship with Struck off Companies

Where the company has any transactions with companies struck off under section 248 of the Companies Act, 2013 or section 560 of Companies Act, 1956, the Company shall disclose the following details:-
Relationship with the
Nature of transactions
Name of struck off Company Balance outstanding Struck off company, if any,
with struck-off Company
to be disclosed
Investments in securities
Receivables
Payables
Shares held by struck-off
Other outstanding balances
Company
(to be specified

x Registration of charges or satisfaction with Registrar of Companies

Where any charges or satisfaction yet to be registered with Registrar of Companies beyond the statutory period, details and reasons thereof shall be disclosed.

XI Compliance with number of layers of companies

Where the company has not complied with the number of layers prescribed under clause (87) of section 2 of the Act read with Companies (Restriction on number of Layers) Rules, 2017, the name and CIN of the companies beyond the specified layers and the relationship/extent of holding of the company in such downstream companies shall be disclosed.

XI Ratios
Ratios Numerator Denominator Current Reporting Period Previous reporting period % of Change
Debt Equity Ratio Debt Capital Shareholder's Equity #DIV/0! #DIV/0!
Debt Service coverage ratio Debt Service 0.00 0.00
EBITDA-CAPEX
(Int+Principal)
Average Shareholder’s
Return on Equity Ratio Profit for the year #DIV/0! #DIV/0!
Equity
Inventory Turnover Ratio COGS Average Inventory 0.00 0.00
Trade Receivables turnover ratio Net Sales
Total Purchases (Fuel Cost + Average trade receivables #DIV/0! #DIV/0!
Trade payables turnover ratio Other Expenses+Closing Closing Trade Payables #DIV/0! #DIV/0!
Net capital turnover ratio Inventory-Opening
Sales Inventory) Workimg capital (CA-CL) #DIV/0! #DIV/0!
Net profit ratio Net Profit Sales #DIV/0! #DIV/0!
Return on Capital employed Earnings before interest and tax Capital Employed #DIV/0! #DIV/0!
Return on investment Net Profit Investment #DIV/0! #DIV/0!

XII Compliance with approved Scheme(s) of Arrangements

Where any Scheme of Arrangements has been approved by the Competent Authority in terms of sections 230 to 237 of the Companies Act, 2013, the Company shall disclose that the effect of such Scheme of Arrangements have been accounted for in the books of account of the Company ‘in accordance with the Scheme’ and ‘in accordance with accounting standards’ and deviation in this regard shall be explained

XIII Utilisation of Borrowed funds and share premium:

 F.Y 2023-2024 F.Y 2022-2023 F.Y 2021-2022
Particulars
(Lacs) (Lacs) (Lacs)
Net Sales /Income
from Business 125.84 77.86 7.06
Operations
Other Income 0 0 0
Total Income 125.84 77.86 7.06
Less Expenditure 122.58 84.89 16.71
Less Interest 3.22 1.26 0
Profit before
0.04 -8.29 -9.65
Depreciation
Less Depreciation 0.88 0.97 0.62
Profit after
depreciation and (0.84) -9.25 -10.27
Interest
Less Current Income
0 0 0
Tax
Less Previous year
adjustment of 0 0 0
Income Tax
Less Deferred Tax (0.07) -0.01 -0.05

Net Profit after Tax (0.77) -9.24 -10.22

Dividend (including
Interim if any and 0 0 0
final)
Net Profit after
(0.77) -9.24 -10.22
dividend and Tax
Earnings per share
(0.19) -2.31 -5.11
(Basic)
Earnings per Share
(0.19) -2.31 -5.11
(Diluted)